Cited by 365Systemic Lupus Erythematosus ResearchVenous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Antiphospholipid antibodies and venous thromboembolism

Ginsberg, JS, Wells, PS, Brill-Edwards, P, Donovan, D, Moffatt, K, Johnston, M, Stevens, P, Hirsh, J·1995·Blood

DOI 10.1182/blood.v86.10.3685.bloodjournal86103685

Open this paper in CoChat — free account

Abstract

The clinical relevance of antiphospholipid antibodies (APLA) in patients without systemic lupus erythematosus who have venous thromboembolism (VTE) in unknown. Limited evidence suggests that there is an association between the presence of APLA and both initial and recurrent episodes of VTE and that patients with APLA and VTE are resistant to warfarin therapy. Unselected patients with a first episode of clinically suspected deep vein thrombosis or pulmonary embolism were evaluated with objective tests for VTE and with laboratory tests for APLA; the latter included tests for the lupus anticoagulant (LA) and anticardiolipin antibodies (ACLA). Patients with VTE were treated with anticoagulant therapy and observed during and after discontinuation of anticoagulants for symptomatic recurrence of VTE. There was a strong association between LA and VTE (odds ratio, 9.4; 95% confidence interval [CI], 2.1 to 46.2) and 9 to 65 (14%; 95% CI, 7% to 25%) patients with VTE had LA. There was no association between the presence of ACLA and VTE (odds ratio, 0.7; 95%CI, 0.3 to 1.7) because of the high frequency of positive ACLA assays in patients without VTE. None of the 16 patients with VTE and APLA developed recurrent VTE while receiving warfarin therapy. There was no difference in rates of recurrent VTE in patients with or without APLA after anticoagulant therapy was discontinued. The strong association between LA and VTE suggests that testing for LA in patients with VTE is useful. The measurement of ACLA in patients with VTE has no clinical usefulness because the results are abnormal in a high proportion of patients without VTE. Although the presence of APLA in patients with VTE was not associated with resistance to a conventional intensity of warfarin or an increased risk of recurrent VTE after discontinuation of warfarin, a larger study should address these issues in a subgroup of patients with VTE and LA.

Integrity signals

Registry

Crossref · 10.1182/blood.v86.10.3685.bloodjournal86103685

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor Deficiencies
Proctor, R. R., & Rapaport, S. I. (1961) · American Journal of Clinical Pathology · doi:10.1093/ajcp/36.3.212 · Cited by 989
Detection of Deep-Vein Thrombosis by Real-Time B-Mode Ultrasonography
Lensing, A. W. A., Prandoni, P., Brandjes, D. P. M., Huisman, P. M., Vigo, M., Tomasella, G., Krekt, J., ten Cate, J. W., Huisman, M. V., & Buller, H. R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200602 · Cited by 868
Roentgen Diagnosis of Venous Thrombosis in the Leg
Rabinov, K. R. (1972) · Archives of Surgery · doi:10.1001/archsurg.1972.04180020014004 · Cited by 741
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700
Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546
Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-997 · Cited by 526
Untitled work
(1963) · PubMed · Cited by 512

Show all 51 references

Sorted by citations

Items 301–364 of 364

Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease.
Bazzan, M., Tamponi, G., Vaccarino, A., Montaruli, B., Aluffi, E., Schinco, P., Pannocchia, A., Borchiellini, A., Rabbia, C., & Pileri, A. (1997) · PubMed · Cited by 1
Epidemiology and prevention of deep vein thrombosis
Castellucci, L. A., & Wells, P. S. (2014) · doi:10.2217/fmeb2013.13.151 · Cited by 1
Nichtinvasive Untersuchungsverfahren
Hach-Wunderle, V., Scheffler, A., & Strauss, A. L. (1998) · Springer eBooks · doi:10.1007/978-3-662-08104-4_34 · Cited by 1
Venous Thromboembolism
Villanueva, A. G. (2001) · Springer eBooks · doi:10.1007/978-1-4757-6645-5_22 · Cited by 1
Author Reply
Lahey, J. M., Kearney, J. F., Tanaka, S. C., & Tunç, M. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00702-4 · Cited by 1
Molekulare Grundlagen von Thrombose und Embolie in der Schwangerschaft
Zotz, R. B., Gerhardt, A., & Scharf, R. E. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57533-4_9
Organization of a Randomized Clinical Trial for the Prevention of Recurrent Thrombosis in the Antiphospholipid Syndrome: the WAPS Project (Warfarin in Antiphospholipid Syndrome)
Finazzi, G., Marchioli, R., & Barbui, T. (1998) · Springer eBooks · doi:10.1007/978-3-642-80403-8_23
Validación del Nuevo Ensayo Tiempo de Bothrops atrox diluido (dBat) para la Detección de Anticoagulante Lúpico
Donayre, P. J. O. (2014) · Anales de la Facultad de Medicina · doi:10.15381/anales.v61i1.4244
Antiphospholipid antibodies and lipoprotein(a) in obese children
Pascut, D., Princi, T., Donato, M., Tamaro, G., & Parco, S. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.01182.x
The signification of antiphospholipid antibodies in pregnancy-associated pathologies and venous thromboembolism
Klai, S., Fekih‐Mrissa, N., Mrissa, R., Rachdi, R., & Gritli, N. (2010) · Comparative Clinical Pathology · doi:10.1007/s00580-010-1119-x
Successful primary angioplasty in Hughes syndrome
Osula, S., & Ramsdale, D. R. (2002) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.10142
A Case of Primary Antiphospholipid Antibody Syndrome with Multiple Thromboses Including Thrombotic Occlusion of Abdominal Aorta
Ko, J. Y., Lee, S. H., Kim, J., Lee, B., Yoo, B. S., Choe, K. H., & Yoon, J. (2001) · Korean Circulation Journal · doi:10.4070/kcj.2001.31.7.707
Laboratory Diagnosis of Antiphospholipid Antibodies
Samama, M. M., Horellou, M., & Conard, J. (1997) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/s1064744997000276
Una causa inusual de hematomas
Calle, I. R., Otones, L. L., del Río, P. G., & de la Mata, A. C. (2013) · Anales de Pediatría · doi:10.1016/j.anpedi.2013.10.016
Physiopathologie des affections thrombotiques
Schved, J. (2002) · Archives de Pédiatrie · doi:10.1016/s0929-693x(01)00895-8
Limited Usefulness of Tests of Coagulation Defects for Predicting Symptomatic Pulmonary Embolism after an Initial Episode of Deep Vein Thrombosis
Yasuhara, H., & Muto, T. (2000) · Phlebology The Journal of Venous Disease · doi:10.1177/026835550001500207
Avaliação do desempenho dos reagentes do tempo de tromboplastina parcial ativada utilizados para detectar o anticoagulante lúpico
Chiuso‐Minicucci, F., Ferrari, I. C., & Santos, I. A. T. [. (2005) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442005000300004
Diagnostic biologique des anticoagulants circulants de type lupique (lupus anticoagulants)
Arnoux, D., Boutière, B., & Sampol, J. (1997) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(97)80145-x
Clinical implications of the new understanding of thrombophilia
Moll, S., & Gulba, D. C. (2000) · Steinkopff eBooks · doi:10.1007/978-3-642-51190-5_3
Shrinking central nervous system in systemic lupus erythematosus
Mok, C. C., Mak, A., & Tsui, E. Y. K. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.009084
Antiphospholipid antibodies in venous thromboembolism patients younger than 50 years old.
Halvani, A., Owlia, M. B., & Mehrpour, G. (2010) · Tanaffos: Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis
Identification of anti-beta₂ glycoprotein I auto-antibody regulated gene targets in the primary antiphospholipid syndrome using gene microarray analysis
Hamid, C. (2007)
Gene Polymorphism Analysis Related to the Development of Deep Vein Thrombosis
Song, E. K., Seon, J., Park, S., Kim, Y., & Park, Y.-H. (2008) · The Journal of the Korean Orthopaedic Association · doi:10.4055/jkoa.2008.43.6.766
Antiphospholipid Antibodies Do Not Seem to Be Associated With Deep Vein Thrombosis: A Case Control Study
Zanon, E., Simioni, P., Saracino, M. A., Prandoni, P., Girolami, B., Sardella, C., & Girolami, A. (1997) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602969700300303
T HE A NTIPHOSPHOLIPID S YNDROME
Evine, S. L., Are, D. W., Ranch, B., & Auch, J. O. R. (2002)
Chapitre 25 – Stratégie du bilan étiologique de la maladie thrombo-embolique veineuse
Pernod, G. (2015) · doi:10.1016/b978-2-294-74489-1.00025-5
Geen indicatie voor trombofilieonderzoek bij patiënten met idiopathische veneuze trombo-embolie en hun familieleden
Caldwell, Holt, P., McLean, B. K., Seidenberg, B., Fe, S., Dy, G., Hw, D., & Bj, S. (2001)
Zasady leczenia wstępnego i wtórnej profilaktyki przeciwzakrzepowej w zatorze tętnicy płucnej Guidelines for primary treatment and secondary antithrombosis prevention of pulmonary embolism
Kostrubiec, M., & Pruszczyk, P. (2010)
Síndrome antifosfolipídica e morbidade gestacional Antiphospholipid syndrome and morbidity gestation
Fagundes, I., Borges, R. B. K., Schiavo, N., Neumann, J., von Mühlen, C. A., & Staub, H. L. (2005) · DOAJ (DOAJ: Directory of Open Access Journals)
41 Management of Thrombocytopenia in
Syndrome, H., Galli, M., & Barbui, T. (2000)
THE ANTIPHOSPHOLIPID OR HUGHES' SYNDROME: AN UNDERDIAGNOSED CAUSE OF THROMBOSIS
Williams, F., & Hunt, B. J. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11658.x
Coagulation Inhibitor Potential: : a global assay for the detection of thrombophilia
Andresen, M. S. (2007) · Duo Research Archive (University of Oslo)
Peripheral Venous Pathomorphology and Pathophysiology
Schellong, S., & Schwarz, T. (2002) · Springer eBooks · doi:10.1007/978-3-642-56225-9_93
study presenting with immune thrombocytopenic purpura: a prospective cohort Antiphospholipid antibodies and antiphospholipid syndrome in patients
Küçükkaya, R. D., Hacıhanefioğlu, A., Turgut, M., & Keskin, H. L. (2011)
Anticoagulation Therapy for the Antiphospholipid Syndrome
Goodnight, S. H. (2001) · CRC Press eBooks · doi:10.1201/9781420040395-44
Laboratory Testing for Antiphospholipid Syndrome
Ioannou, Y., & Krilis, S. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10052-x
Venous thromboembolism: Lifetime risk and novel risk factors
Bell, E. J. (2015) · University of Minnesota Digital Conservancy (University of Minnesota)
Eular On-line Course on Rheumatic Diseases - module n°19
Khamashta, M. A., Bertolaccini, M. L., & Østensen, M. (2008)
Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome
Amengual, O., Bertolaccini, M. L., & Atsumi, T. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00004-1
Prevention of recurrent thrombosis in antiphospholipid antibody syndrome
Windyga, J. (2004) · Via Medica Journals
Inherited thrombophilia in patients with chronic venous leg ulceration
Wiszniewski, A., Bykowska, K., Jaśkowiak, W., Bilski, R., & Ratajczak, J. (2009) · Acta Angiologica
Purpura fulminans: A rare presentation of antiphospholipid syndrome
K, A. S. M., T, N. Q. O., Sudheer Chauhan, Y., & Jose Cervantes, Y. (2017) · International Journal of Case Reports and Images · doi:10.5348/ijcri-201716-cl-10126
Management of antiphospholipid syndrome in adults: The European League Against Rheumatism (EULAR) recommendations
Veselinović, M., Lucic, A. T., Jakovljevic, V. L., & Aničić, A. (2019) · Medicinski casopis · doi:10.5937/mckg53-23292
Antiphospholipid Syndrome
Erkan, D., Salmon, J. E., & Lockshin, M. D. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00082-7
Antiphospholipid Syndrome, Review of 24 Iraqi patients
Yassin, A. K. (2007) · Journal of the Faculty of Medicine
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis
Root, P., & Isman, T. L. (2005)
Antiphospholipid Syndrome – Early Pregnancy Loss
Thakur, N. (2021) · Asian Journal of Nursing Education and Research · doi:10.52711/2349-2996.2021.00136
Laboratory diagnosis of antiphospholipid antibodies
Samama, M. M., Horellou, M., & Conard, J. (1997) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1002/(sici)1098-0997(1997)5:2
ANTIPHOSPHOLIPID ANTIBODY (aPL) PRESENCE IN COVID-19 PATIENTS
Neijmann, S. T., Kural, A., Işıksaçan, N., Karabela, Ş. N., Ördekçi, S., Günver, M. G., & Gedikbaşı, A. (2022) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.1059659
Biological thrombophilia
Pernod, G. (2014) · doi:10.2217/fmeb2013.13.33
Impacto da pesquisa laboratorial de trombofilia na prevençao secundaria e orientação dos doentes com troboembolismo venoso
Paschôa, A. F. (2006) · doi:10.47749/t/unicamp.2006.372926
Announcing a New Online Feature
(2010) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(10)00976-x
Lupus Anticoagulants: Mechanistic and Diagnostic Considerations
Arnout, J., & Vermylen, J. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_23
Antiphospholipid antibody syndrome
Parida, J. R., Misra, D. P., Wakhlu, A., & Agarwal, V. (2014) · Clinical Queries Nephrology · doi:10.1016/j.cqn.2014.03.007
Antiphospholipid Antibody Syndrome
Zambon, M., Cappelli, D., & Berlot, G. (2012) · Springer eBooks · doi:10.1007/978-88-470-2448-9_13
Anticoagulation Therapy for the Antiphospholipid Syndrome
Goodnight, S. H. (2001) · CRC Press eBooks · doi:10.1201/9781420040395.ch35
Antiphospholipid Syndrome, Review of 24 Iraqi patients
Yassin, A. K., & Jawad, A. M. (2007) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbagdad.4921380
Deep vein thrombosis
Ouasif, H., Yahyaoui, H., Aitameur, M., & Chakour, M. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.18.1.0436
Riddles of Lupus Anticoagulant in children
Jamal, C. Y. (2024) · Bangladesh Journal of Child Health · doi:10.3329/bjch.v46i3.72671
A Case Report of Larsen’s Syndrome, Antiphospholipid Syndrome, Diaphragmatic Hernia, and a Colon Polyp: A Hidden Association or a Mere Coincidence
Mallik, S., Khan, S., Rajani, A. J., Amin, J., & Raval, D. M. (2024) · Journal of the Association of Physicians of India · doi:10.59556/japi.72.0733
Spinal Cord Infarction Presenting as Cauda Equina Syndrome With Concurrent Pulmonary Embolism: A Case Report
Rajeev, A. S., Baby, M. M., & Krishnan, S. (2025) · Cureus · doi:10.7759/cureus.93778
Anticoagulant Therapy with Warfarin for Thrombotic Disorders
Harker, L. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-59942-2_12
ISCHEMIC STROKE IN YOUNG ADULTS: A MODERN OVERVIEW
Spychalska, M., Bielak, A., Foryś, A., Kałwak, M., Kuczwalska, D., & Trocka, D. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4410
Hypercoagulable Disorders—Reply
Thomas, R. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1785-a

Authors: Ginsberg, J., Wells, P., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P., & Hirsh, J.
Affiliations: McMaster University (CA)
ORCID: Hirsh, J
Venue: Blood
Publisher: American Society of Hematology
Published: 1995-11-15
Volume: 86
Issue: 10
Pages: 3685-3691
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood.v86.10.3685.bloodjournal86103685
OpenAlex: W2157778986
Cited by: 365
References: 51
Citations by year: 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 8 · 2013: 7 · 2012: 7
FWCI: 14.59
Type: journal article
Language: en
Open access: closed
Locations: Blood (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: antiphospholipid antibodies, venous thromboembolism, lupus anticoagulant, anticardiolipin antibodies, deep vein thrombosis, pulmonary embolism, recurrent venous thromboembolism, warfarin resistance, anticoagulation, systemic lupus erythematosus
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Anticoagulants, Autoimmune Diseases, Female, Humans, Male, Middle Aged, Ontario, Predictive Value of Tests, Prospective Studies, Pulmonary Embolism, Thrombophlebitis, Warfarin, Lupus Coagulation Inhibitor, Antiphospholipid Syndrome, Antibodies, Antiphospholipid, Antibodies, Anticardiolipin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antiphospholipid antibodies and venous thromboembolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks